ACE inhibitors in elderly patients with hypertension. Special considerations

Area of Science:

• Cardiology
• Pharmacology
• Nephrology

Background:

• Angiotensin converting enzyme (ACE) inhibitors are established antihypertensive and vasodilatory agents.
• They are frequently the first-line treatment for hypertension in elderly patients.

Purpose of the Study:

• To evaluate the efficacy and benefits of ACE inhibitors in various patient populations.
• To assess the impact of long-term ACE inhibition on survival and morbidity.
• To explore the advantages of combination therapy with ACE inhibitors.

Main Methods:

• Review of existing literature on ACE inhibitor use in hypertension, heart failure, post-myocardial infarction, and diabetes.
• Analysis of data on blood pressure control, organ perfusion, and adverse effects in elderly patients.
• Examination of outcomes when ACE inhibitors are used as monotherapy versus in combination with other agents.

Main Results:

• ACE inhibitors improve survival and reduce cardiovascular, cerebral, and renal morbidity with long-term use.
• In elderly atherosclerotic patients, they effectively control blood pressure and preserve organ perfusion with few side effects.
• Monotherapy with ACE inhibitors has limitations, but combination therapy with diuretics, nitrates, or calcium antagonists offers significant advantages.

Conclusions:

• ACE inhibitors are beneficial for elderly hypertensive patients and those with specific cardiovascular or renal conditions.
• Combination therapy with ACE inhibitors preserves renal function and prevents left heart hypertrophy.
• The choice among different ACE inhibitors is often based on physician preference due to lack of major efficacy differences.